Document
IPR2016-00280, No. 1025-2 Exhibit - Ex 1025 Curriculum Vitae of Nandita Ganguly Das (P.T.A.B. Dec. 17, 2015)
Cite Document
IPR2016-00280, No. 1025-2 Exhibit - Ex 1025 Curriculum Vitae of Nandita Ganguly Das (P.T.A.B. Dec. 17, 2015)
+ More Snippets
Document
IPR2016-00280, No. 1009-2 Exhibit - Ex 1009 Administrative Documents and Correspondence Part 6, NDA for Suboxone Tablets NDA Part 6 (P.T.A.B. Dec. 17, 2015)
Cite Document
IPR2016-00280, No. 1009-2 Exhibit - Ex 1009 Administrative Documents and Correspondence Part 6, NDA for Suboxone Tablets NDA Part 6 (P.T.A.B. Dec. 17, 2015)
+ More Snippets
Document
IPR2016-00280, No. 1016-2 Exhibit - Ex 1016 Campbell The history of the development of buprenorphine (P.T.A.B. Dec. 17, 2015)
Cite Document
IPR2016-00280, No. 1016-2 Exhibit - Ex 1016 Campbell The history of the development of buprenorphine (P.T.A.B. Dec. 17, 2015)
+ More Snippets
Document
SUBOXONE, 022410, Letter (Orange Book Oct. 26, 2018)
Cite Document
SUBOXONE, 022410, Letter (Orange Book Oct. 26, 2018)
+ More Snippets
Document
SUBOXONE, 022410, Letter (Orange Book Jun. 11, 2018)
Cite Document
SUBOXONE, 022410, Letter (Orange Book Jun. 11, 2018)
+ More Snippets
Document
SUBOXONE, 022410, Label (Orange Book Jun. 11, 2018)
Cite Document
SUBOXONE, 022410, Label (Orange Book Jun. 11, 2018)
+ More Snippets
Document
IPR2014-00325, No. 1054 Exhibit - Exhibit 1054 Petitioners Objections to Evidence (P.T.A.B. Feb. 24, 2015)
Cite Document
IPR2014-00325, No. 1054 Exhibit - Exhibit 1054 Petitioners Objections to Evidence (P.T.A.B. Feb. 24, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1031 Exhibit - Declaration of Christine Siegwarth Meyer (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1031 Exhibit - Declaration of Christine Siegwarth Meyer (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1035 Exhibit - IPR2014 00998 8322 Joinder for Motion (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1035 Exhibit - IPR2014 00998 8322 Joinder for Motion (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1028 Exhibit - Thomas P Johnston Deposition Transcript (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1028 Exhibit - Thomas P Johnston Deposition Transcript (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1048 Exhibit - Jessie Cheng An Antitrust Analysis of Product Hopping in the Pharmaceutical Industry (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1048 Exhibit - Jessie Cheng An Antitrust Analysis of Product Hopping in the Pharmaceutical Industry (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1034 Exhibit - IPR2014 00998 8322 Institution Decision (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1034 Exhibit - IPR2014 00998 8322 Institution Decision (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1052 Exhibit - Lachman Consultant Services, Inc Citizen Petition (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1052 Exhibit - Lachman Consultant Services, Inc Citizen Petition (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1042 Exhibit - FDA Frequently Asked Questions on Patents and Exclusivity (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1042 Exhibit - FDA Frequently Asked Questions on Patents and Exclusivity (P.T.A.B. Jan. 30, 2015)
+ More Snippets
Document
IPR2014-00325, No. 1037 Exhibit - 832CN First Rejection NFOA (P.T.A.B. Jan. 30, 2015)
Cite Document
IPR2014-00325, No. 1037 Exhibit - 832CN First Rejection NFOA (P.T.A.B. Jan. 30, 2015)
+ More Snippets